Artelo Biosciences
ARTL
16 hedge funds and large institutions have $984K invested in Artelo Biosciences in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 2 closing their positions.
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
23% more funds holding
Funds holding: 13 → 16 (+3)
3.62% less ownership
Funds ownership: 8.11% → 4.49% (-3.6%)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
37% less capital invested
Capital invested by funds: $1.57M → $984K (-$585K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$99.5K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$37.3K |
| 3 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$19.6K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$17.8K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$17.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$126K |
| 2 |
BFM
Boothbay Fund Management
New York
|
-$97K |
| 3 |
HighTower Advisors
Chicago,
Illinois
|
-$40.9K |
| 4 |
Two Sigma Advisers
New York
|
-$14.2K |
| 5 |
LCM
LVM Capital Management
Portage,
Michigan
|
-$9K |
ARTL Hedge Fund Activity: Q4 2021 in Review
16 of the 6,519 institutional investors tracked by Wall St. Rank reported a position in Artelo Biosciences (ARTL) for Q4 2021, worth a combined $984K — down 37% from $1.57M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new ARTL positions and 2 closed out — a net gain of 3 holders — while 3 added to existing stakes and 4 trimmed.
The largest buyer was Virtu Financial, adding an estimated $99.5K. The largest seller was Renaissance Technologies, cutting an estimated $126K.
- 16 institutional investors held Artelo Biosciences (ARTL) as of Q4 2021, up from 13 in Q3 2021.
- Funds reported $984K of Artelo Biosciences stock for Q4 2021, down 37% quarter-over-quarter.
- 5 funds opened new Artelo Biosciences positions in Q4 2021 and 2 closed out, a net change of +3 holders.
- The largest Artelo Biosciences buyer in Q4 2021 was Virtu Financial, an estimated $99.5K added.
- The largest Artelo Biosciences seller in Q4 2021 was Renaissance Technologies, an estimated $126K sold.
Based on aggregated 13F filings for Q4 2021.